港股早評:三大指數低開 科技股普跌 生物科技股逆勢走強
格隆匯4月11日丨港股主要指數低開,恆指跌0.84%,國指跌0.93%,恆生科技指數跌1.29%。盤面上,大型科技股漲跌不一,美團跌5.4%,百度跌4%,快手、騰訊跌1%,小米、京東、阿里巴巴皆走低;燃氣股大跌居前,汽車股、家電股、煤炭股、電力股、海運及港口股、石油股多數走低,中海油績後跌2.23%;另一方面,生物科技股上漲明顯,雲頂新耀、心通醫療均漲超4%,食品股康師傅、統一企業中國均高開。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.